Outcomes | Total n = 5010 | Pen-A patients n = 1254 | Non-Pen-A patients n = 3756 | Unadjusted B | 95% CI | Adjusted Ba | 95% CI |
---|---|---|---|---|---|---|---|
No. of AB per PY (%)d | 2110 (100.0%) | 1051 (100.0%) | 1059 (100.0%) | 0.556 | 0.377 to 0.736 | 0.392 | 0.183 to 0.600 |
No. of 2nd choice AB per PYb (%)d | 269.4 (5.4%) | 93.7 (7.5%) | 175.7 (4.7%) | 0.039 | −0.005 to 0.084 | 0.024 | 0.008 to 0.111 |
Various types of antibiotics: No. of AB per PY(%)d | |||||||
Tetracyclins | 332 (15.7%) | 136 (12.9%) | 195 (18.4%) | 0.057 | 0.036 to 0.078 | 0.029 | 0.005 to 0.053 |
BL, penicillins | 501 (23.7%) | 142 (13.5%) | 372 (35.1%) | 0.014 | −0.008 to 0.037 | −0.023 | −0.049 to 0.002 |
BL, others | 21 (1.0%) | 7 (0.7%) | 14 (1.3%) | 0.002 | −0.010 to 0.013 | 0.004 | −0.010 to 0.018 |
Sulfonamides/trimethoprim | 140 (6.6%) | 70 (6.7%) | 71 (6.7%) | 0.037 | 0.022 to 0.051 | 0.027 | 0.010 to 0.043 |
Macrolidesc | 537 (25.4%) | 458 (43.6%) | 78 (7.4%) | 0.345 | 0.176 to 0.514 | 0.263 | 0.066 to 0.60 |
Quinolones | 195 (9.2%) | 78 (7.4%) | 116 (11.0%) | 0.032 | 0.000 to 0.063 | 0.034 | −0.002 to 0.007 |
Other antibacterials | 373 (17.7%) | 159 (15.1%) | 214 (20.2%) | 0.070 | 0.045 to 0.096 | 0.058 | 0.029 to 0.087 |
No. of GP contacts per PY | 6.3 | 16.0 | 3.0 | 3.732 | 3.089 to 4.375 | 3.052 | 2.316 to 3.788 |